Amgen has announced it is developing its already marketed psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the SARS-CoV-2 coronavirus. Otezla ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback